Going into detail on what this term means and how it relates to health guidelines. This article may be incomplete.
Landmark trial demonstrating, for the first time, that "among patients at high risk for cardiovascular events but without diabetes, targeting a systolic blood pressure of less than 120 mm Hg, as compared with less than 140 mm Hg, resulted in lower rates of fatal and nonfatal major cardiovascular events and death from any cause, although significantly higher rates of some adverse evets were observed in the intensive-treatment group." SPRINT Trial: A Randomized Trial of Intensive versus Standard Blood-Pressure Control | NEJM